Zolpidem: here's the fair price
This is what US pharmacies pay, on average, for zolpidem. Use it to spot a fair cash price, and feel good about asking for one.
Zolpidem Tartrate 5 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Zolpidem Tartrate 5 Mg Tablet. Pharmacies pay about $1.04 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| ZOLPIDEM TARTRATE 5 MG TABLETGeneric | $0.03 per tablet or capsule | $1.04 | 10/21/2026 |
| ZOLPIDEM TARTRATE 10 MG TABLETGeneric | $0.04 per tablet or capsule | $1.17 | 10/21/2026 |
| ZOLPIDEM TART ER 6.25 MG TABGeneric | $0.10 per tablet or capsule | $3.07 | 10/21/2026 |
| ZOLPIDEM TART ER 12.5 MG TABGeneric | $0.12 per tablet or capsule | $3.54 | 10/21/2026 |
| ZOLPIDEM TART 1.75 MG TAB SLGeneric | $4.92 per tablet or capsule | $147.52 | 10/21/2026 |
| ZOLPIDEM TART 3.5 MG TABLET SLGeneric | $5.80 per tablet or capsule | $173.99 | 10/21/2026 |
| ZOLPIDEM TARTRATE 7.5 MG CAPGeneric | $7.99 per tablet or capsule | $239.68 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Zolpidem Tartrate Tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem Tartrate Tablets has been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies ( 14 )]. The clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. Zolpidem Tartrate Tablets, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. ( 1 )
Common side effects (FDA label)
6 ADVERSE REACTIONS The following serious adverse reactions are discussed in greater detail in other sections of the labeling: Complex Sleep Behaviors [see Warnings and Precautions ( 5.1 )] CNS-depressant effects and next-day impairment [see Warnings and Precautions ( 5.2 )] Severe anaphylactic and anaphylactoid reactions [see Warnings and Precautions ( 5.4 )] Abnormal thinking and behavior changes [see Warnings and Precautions ( 5.5 )] Withdrawal effects [see Warnings and Precautions ( 5.9 )] Most commonly observed adverse reactions were: Short-term (<10 nights): Drowsiness, dizziness, and...
Drug interactions (from the label)
7 DRUG INTERACTIONS CNS depressants, including alcohol: Possible adverse additive CNS- depressant effects ( 5.1 , 7.1 ) Opioids: Concomitant use may increase risk of respiratory depression ( 5.7 , 7.1 ) Imipramine: Decreased alertness observed ( 7.1 ) Chlorpromazine: Impaired alertness and psychomotor performance observed ( 7.1 ) CYP3A4 inducers (rifampin or St. John's wort): Combination use may decrease effect ( 7.2 ) Ketoconazole: Combination use may increase effect ( 7.2 ) 7.1 CNS-Active Drugs CNS Depressants Coadministration of Zolpidem with other CNS depressants increases the risk of CNS depression. Concomitant use of Zolpidem with these drugs may increase drowsiness and psychomotor...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS CNS-Depressant Effects: Impairs alertness and motor coordination including risk of morning impairment. Risk increases with dose and use with other CNS depressants and alcohol. Caution patients against driving and other activities requiring mental alertness the morning after use. Instruct patients on correct use. ( 5.2 ) Need to Evaluate for Comorbid Diagnoses: Re-evaluate if insomnia persists after 7 to 10 days of use. ( 5.3 ) Severe Anaphylactic/Anaphylactoid Reactions: Angioedema and anaphylaxis have been reported. Do not rechallenge if such reactions occur. ( 5.4 ) Abnormal Thinking and Behavioral Changes: Changes including decreased inhibition, bizarre...
Source: FDA drug label via openFDA, label effective 2023-11-16. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.